Transparency in the program is more than just a mechanism for fair pricing—it is a driving force that diminishes the returns ...

The federal government has allocated $1.15 billion to long-covid research without any new treatments yet brought to market. Patients and scientists say it’s time to push harder for breakthroughs.

Funding cuts and regulatory changes could radically reduce Medicaid, the largest program providing medical and health-related ...

Tempus AI is projected to achieve 30% YoY top line growth in Q4 2024 as presented in its preliminary results. Click here to ...

Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...

Although Medicare enrollees typically don't pay a premium for Part A, which covers hospital care, there's a cost for being ...

A shortage of private medical specialists in Tasmania is forcing privately insured patients onto already long public hospital ...

Across the country, whether it’s about skyrocketing costs or access to care, there seems to be wide agreement that health ...

A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...

The murder of United Healthcare CEO Brian Thompson on December 3 focused national attention on the denial of coverage claims ...

Dr Tsun Sean Law details the ARISE trials and outlines other orthobiologic treatments currently available — but not yet ...

Fewer GP clinics than ever will take new bulk-billed customers and out-of-pocket charges continue to rise, in data labelled ...